Literature DB >> 26712499

High rates of obesity and greater associated disability among people with rheumatoid arthritis in Canada.

Inés Colmegna1,2, Carol A Hitchon3, María Celia Bazán Bardales4, Lekha Puri4, Susan J Bartlett4,5.   

Abstract

Obesity in rheumatoid arthritis has been associated with increased risk of comorbidities, larger medical costs, decreased quality of life, higher disease activity, and reduced therapeutic responses. We assessed the burden of obesity among rheumatoid arthritis patients and its impact on patient-reported outcomes. Patients receiving care at two Canadian University Centers were included. Height and weight were measured and selected sociodemographic and rheumatoid arthritis (RA) characteristics as well as patient-reported outcomes were obtained. Patients were classified according to WHO criteria and proposed RA cut points, and results were compared with national data. Using WHO criteria, 68 (34 %) RA patients were classified as obese (vs. ~25 % of Canadians). Using RA cut points, 112 (55 %) RA patients were classified as obese. With both classification methods, obese individuals had significantly higher mean HAQ scores and a higher odds of significant disability (HAQ ≥ 1: WHO OR 2.3; 95 % CI 1.2, 4.2 and RA-specific OR 1.8; 95 % CI 1.0, 3.2). Independent of the classification method use, RA patients have significantly higher rates of obesity than national prevalence estimates. Obese RA patients had about twice the odds of reporting moderate to severe disability.

Entities:  

Keywords:  Cardiovascular disease risk; Disability; Obesity; Rheumatoid arthritis

Mesh:

Year:  2015        PMID: 26712499     DOI: 10.1007/s10067-015-3154-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  16 in total

1.  Obesity and cardiovascular risk factors in rheumatoid arthritis.

Authors:  D J Armstrong; E M McCausland; A D Quinn; G D Wright
Journal:  Rheumatology (Oxford)       Date:  2006-04-21       Impact factor: 7.580

2.  Longterm outcomes and treatment after myocardial infarction in patients with rheumatoid arthritis.

Authors:  Sara S McCoy; Cynthia S Crowson; Hilal Maradit-Kremers; Terry M Therneau; Veronique L Roger; Eric L Matteson; Sherine E Gabriel
Journal:  J Rheumatol       Date:  2013-02-15       Impact factor: 4.666

3.  Gender, body mass index and rheumatoid arthritis disease activity: results from the QUEST-RA Study.

Authors:  D Jawaheer; J Olsen; M Lahiff; S Forsberg; J Lähteenmäki; I G da Silveira; F A Rocha; I M Magalhães Laurindo; L M Henrique da Mota; A A Drosos; E Murphy; C Sheehy; E Quirke; M Cutolo; S Rexhepi; J Dadoniene; S M M Verstappen; T Sokka
Journal:  Clin Exp Rheumatol       Date:  2010-08-30       Impact factor: 4.473

4.  Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis.

Authors:  Maria E C Sandberg; Camilla Bengtsson; Henrik Källberg; Annmarie Wesley; Lars Klareskog; Lars Alfredsson; Saedis Saevarsdottir
Journal:  Ann Rheum Dis       Date:  2014-05-12       Impact factor: 19.103

5.  Waist circumference based abdominal obesity may be helpful as a marker for unmet needs in patients with RA.

Authors:  T Uutela; H Kautiainen; S Järvenpää; S Salomaa; M Hakala; A Häkkinen
Journal:  Scand J Rheumatol       Date:  2014-01-27       Impact factor: 3.641

6.  Redefining overweight and obesity in rheumatoid arthritis patients.

Authors:  Antonios Stavropoulos-Kalinoglou; Giorgos S Metsios; Yiannis Koutedakis; Alan M Nevill; Karen M Douglas; Athanasios Jamurtas; Jet J C S Veldhuijzen van Zanten; Mourad Labib; George D Kitas
Journal:  Ann Rheum Dis       Date:  2007-02-08       Impact factor: 19.103

7.  Sex differences in assessment of obesity in rheumatoid arthritis.

Authors:  Patricia P Katz; Jinoos Yazdany; Laura Trupin; Gabriela Schmajuk; Mary Margaretten; Jennifer Barton; Lindsey A Criswell; Edward H Yelin
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-01       Impact factor: 4.794

Review 8.  Association of Body Mass Index Categories with Disease Activity and Radiographic Joint Damage in Rheumatoid Arthritis: A Systematic Review and Metaanalysis.

Authors:  Celine Vidal; Thomas Barnetche; Jacques Morel; Bernard Combe; Claire Daïen
Journal:  J Rheumatol       Date:  2015-11-01       Impact factor: 4.666

9.  Association of body fat with C-reactive protein in rheumatoid arthritis.

Authors:  Jon T Giles; Susan J Bartlett; Ross Andersen; Richard Thompson; Kevin R Fontaine; Joan M Bathon
Journal:  Arthritis Rheum       Date:  2008-09

10.  Association of morbid obesity with disability in early inflammatory polyarthritis: results from the Norfolk Arthritis Register.

Authors:  J H Humphreys; S M M Verstappen; H Mirjafari; D Bunn; M Lunt; I N Bruce; D P M Symmons
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-01       Impact factor: 4.794

View more
  5 in total

1.  A systematic review of the association of obesity with the outcomes of inflammatory rheumatic diseases.

Authors:  Yi Xuan Lee; Yu Heng Kwan; Ka Keat Lim; Chuen Seng Tan; Nai Lee Lui; Jie Kie Phang; Eng Hui Chew; Truls Ostbye; Julian Thumboo; Warren Fong
Journal:  Singapore Med J       Date:  2019-06       Impact factor: 1.858

Review 2.  Modified Diet Use in Adults with Temporomandibular Disorders related to Rheumatoid Arthritis: A Systematic Review.

Authors:  Gilheaney Órla; Sibylle Béchet; Margaret Walshe
Journal:  Mediterr J Rheumatol       Date:  2020-06-01

Review 3.  Inflammation, obesity and rheumatic disease: common mechanistic links. A narrative review.

Authors:  Elena Nikiphorou; George E Fragoulis
Journal:  Ther Adv Musculoskelet Dis       Date:  2018-06-27       Impact factor: 5.346

Review 4.  Repurposing existing drugs for cardiovascular risk management: a focus on methotrexate.

Authors:  Arduino A Mangoni; Sara Tommasi; Angelo Zinellu; Salvatore Sotgia; Ciriaco Carru; Matteo Piga; Gian Luca Erre
Journal:  Drugs Context       Date:  2018-11-14

Review 5.  What is a "high" prevalence of obesity? Two rapid reviews and a proposed set of thresholds for classifying prevalence levels.

Authors:  Tim Lobstein; Jo Jewell
Journal:  Obes Rev       Date:  2021-09-28       Impact factor: 10.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.